Paris, France

Cecile Guichard

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cecile Guichard: Innovator in Medical Research

Introduction

Cecile Guichard is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the study of ulcerative colitis and its complications. Her innovative work has led to the development of a unique animal model that aids in understanding this complex disease.

Latest Patents

Cecile Guichard holds a patent for a non-human animal model for ulcerative colitis and its main complications. This invention specifically addresses primary sclerosing cholangitis and colorectal cancer. The model involves a transgenic non-human animal with a targeted disruption in the IL10 and NOX1 genes, ensuring that these genes are not expressed in the animal. This groundbreaking work has the potential to enhance research and treatment options for patients suffering from ulcerative colitis.

Career Highlights

Cecile is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she conducts her research. Her dedication to advancing medical science is evident in her innovative approaches and the impact of her work on the understanding of gastrointestinal diseases.

Collaborations

Cecile collaborates with esteemed colleagues, including Eric Ogier-Denis and Xavier Treton. Their combined expertise contributes to the advancement of research in the field of ulcerative colitis and related conditions.

Conclusion

Cecile Guichard's contributions to medical research through her innovative patent and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in understanding and treating ulcerative colitis and its complications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…